Structural basis for binding of potassium-competitive acid blockers to the gastric proton pump

Saki Tanaka, Mikio Morita, Tatsuya Yamagishi, Hridya Valia Madapally, Kenichi Hayashida, Himanshu Khandelia, Christoph Gerle, Hideki Shigematsu, Atsunori Oshima, Kazuhiro Abe

Research output: Contribution to journalJournal articleResearchpeer-review


As specific inhibitors of the gastric proton pump, responsible for gastric acidification, K+-competitive acid blockers (P-CABs) have recently been utilized in the clinical treatment of gastric acid-related diseases in Asia. However, as these compounds have been developed based on phenotypic screening, their detailed binding poses are unknown. We show crystal and cryo-EM structures of the gastric proton pump in complex with four different P-CABs, tegoprazan, soraprazan, PF-03716556 and revaprazan, at resolutions reaching 2.8 Å. The structures describe molecular details of their interactions and are supported by functional analyses of mutations and molecular dynamics simulations. We reveal that revaprazan has a novel binding mode in which its tetrahydroisoquinoline moiety binds deep in the cation transport conduit. The mechanism of action of these P-CABs can now be evaluated at the molecular level, which will facilitate the rational development and improvement of currently available P-CABs to provide better treatment of acid-related gastrointestinal diseases.

Original languageEnglish
JournalJournal of Medicinal Chemistry
Issue number11
Pages (from-to)7843-7853
Publication statusPublished - 9. Jun 2022


Dive into the research topics of 'Structural basis for binding of potassium-competitive acid blockers to the gastric proton pump'. Together they form a unique fingerprint.

Cite this